The metabolic syndrome in type 1 diabetes: does it exist and does it matter?

Journal of Diabetes and Its Complications
Margaret McGillDennis K Yue

Abstract

The significance of the metabolic syndrome in type 1 diabetes is not well understood. This study aimed to estimate its prevalence and attendant complications. Four hundred twenty-seven type 1 diabetic subjects were grouped according to the presence or absence of metabolic syndrome (WHO criteria). Macro- and microvascular complications were compared between the groups as individual and as composite endpoints. Data were analyzed for the total cohort and in subgroups according to duration of diabetes quartiles (<6.9, 7-12.9, 13-19.9, and >20 years) and year of presentation. Fifteen percent of individuals fulfilled the WHO criteria for metabolic syndrome, and of these, 26.9% were insulin resistant, as compared with 3.4% of those without metabolic syndrome [odds ratio (OR)=8.9, P=.001]. Both BMI and metabolic syndrome showed an increasing trend from 1992 to 2003. Those with metabolic syndrome required significantly higher insulin dosage [0.9 (0.7-1.2) vs. 0.6 (0.5-0.9) units/kg, P=.03], were older [35.0 (26.2-47.3) vs. 29.7 (23.4-36.4) years, P=.002], and had longer duration of diabetes [19.7 (10.7-25.6) vs. 12.1 (6.3-17.9) years, P=.0001]. They also had a significantly higher macrovascular composite endpoint (OR=3.3, P=.02) as well...Continue Reading

References

Jun 28, 2000·Diabetes·K V WilliamsT J Orchard
Apr 30, 2003·Diabetes·Charles M AlexanderUNKNOWN National Cholesterol Education Program (NCEP)
Oct 30, 2004·Treatments in Endocrinology·Craig A JefferiesDenis Daneman
Jun 29, 2005·Diabetes Care·Christophe E M De BlockLuc F Van Gaal
Jul 19, 2005·Diabetologia·Edwin A M Gale

❮ Previous
Next ❯

Citations

Mar 19, 2008·Cardiovascular Drugs and Therapy·Paresh DandonaPriya Mohanty
Jun 6, 2009·Irish Journal of Medical Science·F AlSarajS Sreenan
Dec 17, 2008·Current Atherosclerosis Reports·Peter Baginsky
Apr 29, 2010·Current Diabetes Reports·Trevor J Orchard, Tina Costacou
May 10, 2011·Endocrine·Dilek YazıcıSema Akalın
May 12, 2010·International Journal of Clinical Practice·P AschnerUNKNOWN Global Partnership for Effective Diabetes Management
Apr 9, 2011·International Journal of General Medicine·Francisco Arrieta-BlancoAdela Rovira
Apr 4, 2014·International Journal of Endocrinology·Snježana KaštelanDarko Orešković
Jun 17, 2014·Diabetes Management·Ryan J FanteJeffrey M Sundstrom
Jul 27, 2010·Annals of Medicine·Aila J AholaUNKNOWN Finndiane Study Group
Nov 3, 2010·Diabetes Research and Clinical Practice·Denise Prado MomessoRosane Kupfer
Mar 13, 2010·The Journal of Pediatrics·Mariska van VlietHenk J Veeze
Feb 3, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·T T L Pang, P Narendran
Dec 17, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·J S LeedsD S Sanders
Aug 22, 2015·Current Diabetes Reports·Rebecca Schechter, Sirimon Reutrakul
Apr 23, 2015·Journal of Diabetes and Its Complications·Amy BillowViswanathan Mohan
Feb 7, 2009·Diabetes Care·Lena M ThornUNKNOWN Finnish Diabetic Nephropathy (FinnDiane) Study Group
Jul 5, 2016·Journal of Obesity·Alexandra ChowShahzeer Karmali
Feb 26, 2016·Journal of Sleep Research·Sasipas ChontongSirimon Reutrakul
Jul 24, 2014·The Journal of International Medical Research·Romulus TimarCristian Oancea
Apr 21, 2010·Nature Reviews. Endocrinology·Harold E Lebovitz
Jun 14, 2015·Pharmacological Reviews·Debbie L HayJonathan D Roth
Aug 3, 2019·Diabetes, Obesity & Metabolism·Noppadol KietsirirojeRamzi A Ajjan
Dec 15, 2012·Endocrine Reviews·K H WilliamsS M Twigg
Aug 2, 2020·Diabetic Medicine : a Journal of the British Diabetic Association·Angela S LeeJ R Flack
Oct 28, 2019·Cardiovascular Endocrinology & Metabolism·Alicia JenkinsDavid O'Neal
Feb 2, 2021·The Journal of Clinical Endocrinology and Metabolism·Sabrina E Racine-BrzostekZhen Zhao
May 1, 2021·Journal of Clinical Medicine·Cristina ColomAntonio Pérez

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.